Metformin
ميتفورمين · Biguanide (oral antidiabetic) · Endocrine & diabetes
Acts on: Liver Small intestine
Main adverse effects on: Small intestine Kidneys
Mechanism of action
Reduces glucose production by the liver, improves insulin sensitivity and lowers intestinal glucose absorption. Usually does not cause hypoglycaemia on its own.
Uses
First-line treatment for type 2 diabetes.
Side effects
- Nausea, diarrhoea, abdominal pain (less with food)
- Metallic taste
- Vitamin B12 deficiency with long use
- Lactic acidosis (rare, serious) especially in renal impairment
🚫 Contraindications
- Severe renal impairment (eGFR below 30)
- Ketoacidosis or metabolic acidosis
- Severe hepatic impairment and alcohol misuse
- Shock and severe hypoxia
- Temporarily before IV contrast
🤰 Pregnancy
Caution Used in gestational diabetes and PCOS, but insulin is first-line.
🍼 Breastfeeding
Safe / compatible Compatible.
Clinical points & patient counselling
Give with meals. Monitor renal function. Usually held before IV contrast and major surgery per policy.
Tests to monitor
⚕️ Educational content; it does not replace a doctor, pharmacist or official references. Values and doses vary by lab, country and leaflet.